与癌症治疗中使用LAG-3抑制剂相关的皮肤不良反应:系统性审查

相关实验视频

Updated: Jul 9, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Hira Ghani¹, Samavia Khan², Marielle Jamgochian²

¹Nassau University Medical Center East Meadow New York USA.

Skin health and disease

|December 4, 2023

概括

淋巴细胞激活基因-3 (LAG-3) 抑制剂在黑色素瘤治疗中表现有前途,但可能导致皮肤副作用,如皮疹和白风. 需要进一步的研究来了解这些不良事件.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
皮肤病学皮肤病学

背景情况:

免疫疗法,包括PD1和CTLA4抑制剂,是癌症的主要治疗方法.
对当前免疫疗法的耐药性需要针对其他免疫路径的新策略.
淋巴细胞激活基因-3 (LAG-3) 是T细胞功能的关键调节者,使其成为新的癌症治疗的目标.

研究的目的:

审查淋巴细胞激活基因-3 (LAG-3) 抑制剂在黑色素瘤治疗中的皮肤副作用.
综合最近关于与LAG-3抑制相关的皮肤不良事件的文献发现.

主要方法:

使用PRISMA 2022指南进行了全面的文献审查.
在主要的数据库中进行了搜索:PubMed,谷歌学者,Embase,Cochrane和科学网.
确定并分析了三项有关研究,调查了黑色素瘤中的LAG-3抑制剂.

主要成果:

作为单独治疗或组合使用的LAG-3抑制剂与各种皮肤学副作用有关.
报告的副作用包括口腔炎,,皮疹,皮肤干燥,红疹和白风.
这些不良事件突显了LAG-3抑制对皮肤免疫反应的影响.

结论:

拉格-3抑制剂代表了黑色素瘤的治疗选择的发展.
了解和管理相关的皮肤学副作用对于患者护理至关重要.
需要进一步的研究,以充分描述皮肤不良事件,并确定有风险的患者群体.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...